AFIB — Acutus Medical Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapValue Trap
- $18.14m
- -$1.74m
- $16.36m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.35 | ||
| Price to Tang. Book | 0.35 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.24 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.12% | ||
| Return on Equity | -24.63% | ||
| Operating Margin | -82.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2.17 | 2.84 | 8.46 | 17.26 | 16.36 | 19.93 | 31.28 | 65.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Acutus Medical, Inc. is an arrhythmia management company focused on cardiac arrhythmias that are diagnosed and treated. It designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The Company's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. It designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.
Directors
- R. Scott Huennekens CHM (56)
- Vince Burgess PRE (56)
- David Roman CFO (39)
- Steven McQuillan SVP (58)
- David Bonita IND (45)
- Daniella Cramp IND (47)
- Andrew Elbardissi IND (39)
- James Hinrichs IND (53)
- Shaden Marzouk IND (49)
- Niamh Pellegrini IND (54)
- John Sheridan IND (65)
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- March 25th, 2011
- Public Since
- August 6th, 2020
- No. of Shareholders
- 72
- No. of Employees
- 225
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 28,975,677
- Address
- 2210 Faraday Ave Ste 100, CARLSBAD, 92008-7225
- Web
- https://www.acutusmedical.com/us
- Phone
- +1 4422326144
- Auditors
- KPMG LLP
Upcoming Events for AFIB
Q2 2023 Acutus Medical Inc Earnings Call
Q3 2023 Acutus Medical Inc Earnings Release
Similar to AFIB
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Acutus Medical share price?
As of Today at 13:00 UTC, shares in Acutus Medical are trading at $0.72. This share price information is delayed by 15 minutes.
How has the Acutus Medical share price performed this year?
Shares in Acutus Medical last closed at $0.72 and the price had moved by -46.27% over the past 365 days. In terms of relative price strength the Acutus Medical share price has underperformed the S&P500 Index by -53.87% over the past year.
What are the analyst and broker recommendations for Acutus Medical?
The overall consensus recommendation for Acutus Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Acutus Medical dividend yield?
Acutus Medical does not currently pay a dividend.
Does Acutus Medical pay a dividend?
Acutus Medical does not currently pay a dividend.
When does Acutus Medical next pay dividends?
Acutus Medical does not currently pay a dividend.
How do I buy Acutus Medical shares?
To buy shares in Acutus Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Acutus Medical?
As of the previous close price of $0.72, shares in Acutus Medical had a market capitalisation of $21.38m.
Where are Acutus Medical shares listed?
Here are the trading details for Acutus Medical:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: AFIB
What kind of share is Acutus Medical?
Based on an overall assessment of its quality, value and momentum Acutus Medical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Acutus Medical share price forecast for 2023?
The analyst consensus target price for shares in Acutus Medical is $1.71. That is 137.19% above the last closing price of $0.72.
Analysts covering Acutus Medical currently have a consensus Earnings Per Share (EPS) forecast of -$2.44 for the next financial year.
What is the trend in the Acutus Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acutus Medical. Over the past six months, its share price has underperformed the S&P500 Index by -60.87%.
As of the last closing price of $0.72, shares in Acutus Medical were trading -26.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Acutus Medical PE Ratio?
The Acutus Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.72.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Acutus Medical?
Acutus Medical's management team is headed by:
- R. Scott Huennekens - CHM
- Vince Burgess - PRE
- David Roman - CFO
- Steven McQuillan - SVP
- David Bonita - IND
- Daniella Cramp - IND
- Andrew Elbardissi - IND
- James Hinrichs - IND
- Shaden Marzouk - IND
- Niamh Pellegrini - IND
- John Sheridan - IND